在阿司匹林治疗中没有变化的牙提取的评估:一个横截面研究
Ahmed Ali Almuntashri1, Manpreet Kaur2, Yohan Verghese3
1Department of Oral and Dental Health, College of Applied Health Sciences in Al Rass, Qassim University, Kingdom of Saudi Arabia.
Journal of pharmacy & bioallied sciences
|April 10, 2024
概括
牙提取可以在不改变阿司匹林治疗的情况下进行,因为研究表明对出血的影响很小. 这一发现支持在牙科手术期间继续服用低剂量阿司匹林,以确保患者的安全和方便.
科学领域:
- 牙科 牙科是指牙科的专业.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿司匹林通常用于心血管预防.
- 对于接受阿司匹林治疗的患者在牙科手术期间出现出血风险存在担忧.
研究的目的:
- 评估牙拔牙期间继续使用阿司匹林治疗的安全性和影响.
- 为了比较继续服用阿司匹林的患者和暂时停止服用阿司匹林的患者的出血并发症.
主要方法:
- 一项研究涉及100名在阿司匹林治疗期间需要拔牙的患者.
- 患者被分为两组:一组继续服用阿司匹林,另一组在提取前72小时停止服用.
- 测量出血,凝血时间,INR和血小板计数.
主要成果:
- 在继续阿司匹林治疗的组中观察到略有增加的血液损失.
- 在两组之间的平均出血时间和平均INR中发现了显著的差异.
- 在平均凝血时间或平均血小板计数方面没有发现显著差异.
结论:
- 在拔牙期间继续低剂量阿司匹林治疗并没有导致显著的不良出血事件.
- 这些发现表明,阿司匹林治疗可以在没有重大并发症的情况下维持在接受牙科拔牙的患者身上.
相关概念视频
Tonsillitis II: Management
110
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522


